AI Summary
This article discusses the design and synthesis of inhibitors that target both sEH (soluble epoxide hydrolase) and HDAC6 (histone deacetylase 6) for the treatment of inflammatory pain. The research focuses on developing novel compounds that can act on multiple targets to enhance pain relief. This approach could potentially lead to more effective treatments for inflammatory pain by targeting multiple pathways simultaneously.